EP1585495A1 - Utilisation d'oligoglucosamines dans des preparations cosmetiques ou dermatologiques - Google Patents

Utilisation d'oligoglucosamines dans des preparations cosmetiques ou dermatologiques

Info

Publication number
EP1585495A1
EP1585495A1 EP03789355A EP03789355A EP1585495A1 EP 1585495 A1 EP1585495 A1 EP 1585495A1 EP 03789355 A EP03789355 A EP 03789355A EP 03789355 A EP03789355 A EP 03789355A EP 1585495 A1 EP1585495 A1 EP 1585495A1
Authority
EP
European Patent Office
Prior art keywords
acid
cosmetic
oil
dermatological preparations
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03789355A
Other languages
German (de)
English (en)
Inventor
Louis Danoux
Gilles Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
Original Assignee
Cognis France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis France SAS filed Critical Cognis France SAS
Priority to EP03789355A priority Critical patent/EP1585495A1/fr
Publication of EP1585495A1 publication Critical patent/EP1585495A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Definitions

  • the invention is in the field of skin and hair cosmetics and relates to the use of oligoglucosamines or low molecular weight chitosans and others. to stimulate the metabolism of human skin.
  • the related N-acetylglucosamine also proves to be effective in cosmetics, since it primarily promotes the synthesis of hyaluronic acid in human keratinocytes. It is obvious that there is a particular interest in cosmetic chemistry in biocatalysts of this type, the use of which in topically applied preparations ultimately has an advantageous effect on the condition of the skin and hair. However, it is disadvantageous that the performance of glucosamine and its derivatives is not sufficient for practical use. The object of the present invention is therefore derived from this finding, namely to provide active substances which have the complex profile of properties of glucosamines, but which have a significantly higher performance. Description of the invention
  • the invention relates to the use of ohgoglucosamines and / or their derivatives in cosmetic or dermatological preparations for stimulating the metabolism of human skin, in which they are usually present in amounts of 0.01 to 10, preferably 0.1 to 5 and in particular 0.5 up to 1 wt .-% can be included.
  • ohgoglucosamines with an average molecular weight of 500 to 5,000 and preferably 800 to 1,500 in vitro experiments with monomeric glucosamine are distinguished by a significantly greater improvement in fibroblast growth and excellent protection of human keratinocytes against UVB radiation.
  • the ohgoglucosamines according to the invention have a weight average molecular weight of 600 to 1000 g / mol and an acetylene degree of less than 20%.
  • Ohgoglucosamines are biopolymers and belong to the group of hydrocolloids. Chemically speaking, these are partially deacetylated chitins of different molecular weights, which are also known as chitosans and contain the following - idealized - monomer unit:
  • ohgoglucosamines or chitosans are cationic biopolymers under these conditions.
  • the positively charged ohgoglucosamines can interact with oppositely charged surfaces and are therefore used in cosmetic hair and Personal care products and pharmaceutical preparations are used.
  • Chitin preferably the shell remains of crustaceans, is used for their production, which are available in large quantities as cheap raw materials. The chitin is used in a process that was first developed by hackmann et al.
  • Such types are preferably used as the one have an average molecular weight of 10,000 to 500,000 or 800,000 to 1,200,000 daltons and / or a Brookfield viscosity (1% by weight in glycolic acid) below 5000 mPas, a degree of deacetylation in the range from 80 to 88% and an ash content of have less than 0.3% by weight.
  • the chitosans obtainable in this way are polyglucosamines, ie their molecular weight is still far too high for the purposes of the invention.
  • the chitosans are therefore further degraded under the influence of acids and the cleavage products, i.e. the ohgoglucosamines, which now have a molecular weight of 500 to 5,000 and preferably 800 to 1,500, are subjected to membrane filtration in order to remove them from impurities and in particular from salts to free. Then they are freeze-dried. If desired, derivatization can follow, for example the reaction with ethylene oxide.
  • the ohgoglucosamines can be used for the production of cosmetic and / or dermatological preparations, such as, for example, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat compositions, stick preparations or ointments.
  • agents can also be used as further auxiliaries and additives, mild surfactants, oil bodies, emulsifiers, pearlescent waxes, consistency agents, thickeners, superfatting agents, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, UV light protection factors, biogenic active substances, antioxidants, deodorants, Antiperspirants, antidandruff agents, film formers, swelling agents, insect repellents, self-tanners, tyrosine inhibitors (depigmentation agents), hydrotropes, solubilizers, preservatives, perfume oils, dyes and the like.
  • Anionic, nonionic, cationic and / or amphoteric or zwitterionic surfactants can be present as surface-active substances, the proportion of these agents usually being about 1 to 70, preferably 5 to 50 and in particular 10 to 30% by weight.
  • anionic surfactants are soaps, alkyl benzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, alkyl ether sulfates, glycerol ether sulfates, fatty acid ether sulfates, sulfate ether sulfate ethersulfate, sulfate ether sulfate ethersulfate, sulfate ether ethersulfate,
  • anionic surfactants contain polyglycol ether chains, these can have a conventional, but preferably a narrow, homolog distribution.
  • Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, optionally partially oxidized alk (en) yl oligoglycosides or protein alkyl glucose amides, and glucoronyl acid fatty acids (glucoronyl acid), in particular glucoronic acid (glucoronyl) acid, glucoronyl acid (glucoronyl) acid, glucoronol acid (glucoronyl) acid, especially glucoronyl acid, (), Wheat-based products), polyol fatty acid esters, sugar esters, sorb
  • nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • cationic surfactants are quaternary ammonium compounds, such as, for example, dimethyldistearylammonium chloride, and esterquats, in particular quaternized fatty acid trialkanolamine ester salts.
  • amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, histazolinium betaines and sulfobetaines. The surfactants mentioned are exclusively known compounds.
  • Typical examples of particularly suitable mild, ie particularly skin-compatible, surfactants are fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, fatty acid glutamates, ⁇ -olefin sulfonate, alkyl carboxylates, amide carboxylic acid amide carboxylates, ether carboxylic acid fatty acids, fatty acid amide carboxylic acids, ether carboxylic acid sulfate acids, fatty acid amide carboxylates, or protein fatty acid condensates, the latter preferably based on wheat proteins.
  • esters of linear C 6 -C 2 fatty acids with branched alcohols in particular 2-ethylhexanol
  • esters of C 18 -C 38 alkylhydroxycarboxylic acids with linear or branched C 6 -C 22 fatty alcohols cf.
  • diocyl malates especially diocyl malates, esters of linear and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimer diol or trimer triol) and / or Guerbet alcohols, triglycerides based on C 6 -C 0 fatty acids, liquid mono- / di- / Triglyceride mixtures based on C 6 -C 8 fatty acids, esters of C 6 -C 22 fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids, especially benzoic acid, esters of C 2 -C 1 dicarboxylic acids with linear or branched alcohols with 1 to 22 carbon atoms or polyols with 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched primary alcohols, substituted cyclohexanes, linear and branched C6-C 2 fatty alcohol carbonates, such as, for example Dicaprylyl carbonates (
  • Suitable emulsifiers are, for example, nonionic surfactants from at least one of the following groups:
  • Partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, sugar alcohols (eg sorbitol), alkyl glucosides (eg methyl glucoside, butyl glucoside, lauryl glucoside) as well as polyglucosides (eg cellulose) saturated and / or unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 moles of ethylene oxide;
  • Block copolymers e.g. Polyethylene glycol 30 dipolyhydroxystearate; Polymer emulsifiers, e.g. Pemulen types (TR-1, TR-2) from Goodrich;
  • the addition products of ethylene oxide and / or of propylene oxide to fatty alcohols, fatty acids, alkylphenols or to castor oil are known, commercially available products. These are mixtures of homologs whose average degree of alkoxylation is the ratio of the amounts of ethylene oxide and / or propylene oxide and Substrate with which the addition reaction is carried out corresponds.
  • C ⁇ 2 / ⁇ 8 - fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known as refatting agents for cosmetic preparations.
  • Alkyl and or alkenyl oligoglycosides their preparation and their use are known from the prior art. They are manufactured in particular through implementation of glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms.
  • glycoside residue both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to approximately 8 are suitable.
  • the degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.
  • Suitable partial glycerides are hydroxystearic acid monoglyceride, hydroxystearic acid diglyceride, isostearic acid, Isostearinklarediglycerid, oleic acid monoglyceride, oleic acid diglyceride, Ricinolklaremoglycerid, Ricinolklarediglyce- chloride, Linolklaremonoglycerid, Linolklarediglycerid, Linolenchuremonoglycerid, linolenic klarediglycerid, Erucaklaremonoglycerid, Eracaklaklarediglycerid, Weinchuremonoglycerid, Weinklarediglycerid, Citronenklamonoglycerid, Citronendiglycerid, ⁇ pfelklaremo- noglycerid, Malic acid diglyceride and their technical mixtures, which may still contain small amounts of triglyceride from the manufacturing process. Addition products of 1
  • sorbitan sorbitan, sorbitan sesquiisostearate, sorbitan come diisostearate, sorbitan triisostearate, sorbitan monooleate, sorbitan dioleate, trioleate, Sorbitanmonoeracat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, Sorbitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, Sorbitansesquihydroxystearat, sorbitan tandihydroxystearat, Sorbitantrihydroxystearat, Sorbitanmonotartrat , Sorbitan sesquitarate, sorbitan ditartrate, sorbitan tritartrate, sorbitan monocitrate, sorbitan sesquicitrate, sorbitane citrate, sorb
  • polyglycerol esters are polyglyceryl-2 dipolyhydroxystearate (Dehymuls® PGPH), polyglycerol-3-diisostearate (Lameform® TGI), polyglyceryl-4 isostearate (Isolan® GI 34), polyglyceryl-3 oleates, diisostearoyl polyglyce ryl-3 Diisostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl Ether ( Chimexane® NL), Polyglyceryl-3 Distearate (Cremophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Dimerate
  • polystyrene resin examples include the mono-, di- and triesters of trimethylolpropane or pentaerythritol with lauric acid, coconut fatty acid, tallow fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like which are optionally reacted with 1 to 30 mol of ethylene oxide.
  • Typical anionic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic acid or sebacic acid.
  • Zwitterionic surfactants can also be used as emulsifiers.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the betaines, such as NA] alkyl-N, N-dimethylammom 'umglycinate, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyl dimethyl ammonium, and 2-alkyl-3 carboxylmethyl-3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylammoethylhydroxyethyl carboxymethylglycinate.
  • betaines such as NA] alkyl-N, N-dimethylammom 'umglycinate, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyl
  • fatty acid amide derivative known under the CTFA name cocamidopropyl betaine is particularly preferred.
  • Suitable emulsifiers are ampholytic surfactants.
  • Ampholytic surfactants are surface-active compounds which, apart from a C8 / ⁇ 8 alkyl or Acylgrappe in Mo- lekül contain at least one free amino group and at least one -COOH or -SO H group and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylamino-butyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkyl sarcosines, 2-alkylaminopropionic acids and alkylamino acetic acids in each case about 8 to 18 C atoms in the Alkylgrappe .
  • ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C ⁇ 2/18 acyl sarcosine.
  • cationic surfactants are also suitable as emulsifiers, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.
  • Typical examples of fats are glycerides, i.e. Solid or liquid vegetable or animal products, which consist essentially of mixed glycerol esters of higher fatty acids, come as waxes, among others. natural waxes such as Candelilla wax, carnauba wax, Japanese wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax, sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, walnut, lanolin (wool wax), pretzel fat, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, micro waxes chemically modified waxes (hard waxes), e.g.
  • natural waxes such as Candelilla wax, carnauba wax, Japanese wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax, sugar cane wax, ouricury wax, montan wax, beeswax, shell
  • Montanester waxes Montanester waxes, Sasol waxes, hydrogenated jojoba waxes and synthetic waxes, such as Polyalkylene waxes and polyethylene glycol waxes in question.
  • fat-like substances such as lecithins and phospholipids can also be used as additives.
  • lecithins as those glycerophospholipids which are formed from fatty acids, glycerol, phosphoric acid and choline by esterification. Lecithins are therefore often used in the professional world as phosphatidylcholines (PC).
  • Examples of natural lecithins are the cephalins, which are also referred to as phosphatidic acids and are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids.
  • phospholipids are usually understood to be mono- and preferably diesters of phosphoric acid with glycerol (glycerol phosphates), which are generally classed as fats.
  • glycerol phosphates glycerol phosphates
  • sphingosms or sphingolipids are also possible.
  • Pearlescent waxes that can be used are, for example: alkylene glycol esters, especially ethylene glycol distearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partialglyce- ride, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15
  • Suitable consistency agents are primarily fatty alcohols or hydroxyfatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred.
  • Suitable thickeners are, for example, aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydroxypropyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, Polyacrylates (e.g. Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Salcare types from Allied Colloids), polyacrylamides, polymers, polyvinyl alcohol and polyvinylpyrrolidone.
  • aerosil types hydrophilic silicas
  • polysaccharides in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydroxypropyl cellulose,
  • Bentonites such as e.g. Bentone® Gel VS-5PC (Rheox), which is a mixture of cyclopentasiloxane, disteardimonium hectorite and propylene carbonate.
  • Surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as, for example, pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides and electrolytes such as sodium chloride and ammonium chloride are also suitable.
  • Substances such as, for example, lanolin and lecithin and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers. stabilizers
  • Metal salts of fatty acids such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate can be used.
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, e.g. a quaternized hydroxyethyl cellulose available under the name Polymer JR 400® from Amerchol, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers such as e.g.
  • Luviquat® condensation products of polyglycols and amines, quaternized collagen polypeptides, such as, for example, lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, e.g.
  • Amodimethicones, copolymers of adipic acid and dimethylaminohydroxypropyldiethylenetriamine (Cartaretine® / Sandoz), copolymers of acrylic acid with dimethyldiallylammonium chloride (Merquat® 550 / Chemviron), polyaminopolyamides and their crosslinked water-soluble polymers, cationic chitin derivatives such as, for example, quaternized, quaternized, and quaternized , Condensation products from dihaloalkylene, such as Dibromobutane with bisdialkylamines, e.g. Bis-dimethylamino-1,3-propane, cationic guar gum, e.g. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese, quaternized ammonium salt polymers, e.g. Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 from Miranol.
  • Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobornyl acrylate copolymers, methyl vinyl ether, allyl acid arihydride copolymers and their polyols, uncrosslinked polyols and their esters amidopropyltrimethylammoniumchlori ⁇ V acrylate copolymers, octylacrylamide / methyl amyl acylate / tert-butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers, polyvinyl pyrrolidone, vinyl pyrrolidone / vinyl acetate copolymers / dimethyl acrylate vinyl amide and vinyl methacrylate vinyl amide / methacrylate vinyl amide /
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine, glycoside and / or alkyl-modified silicone compounds which can be both liquid and resinous at room temperature.
  • Simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable.
  • UV light protection filters are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine, glycoside and / or alkyl-modified silicone compounds which can be both liquid and resinous at room temperature.
  • Simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable.
  • UV light protection factors are, for example, organic substances (light protection filters) which are liquid or crystalline at room temperature and which are able to absorb ultraviolet rays and absorb the energy in the form of longer-wave radiation, e.g. To give off heat again.
  • UVB filters can be oil-soluble or water-soluble. As oil-soluble substances e.g. to call:
  • 4-aminobenzoic acid derivatives preferably 2-ethyl-hexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and amyl 4- (dimethylamino) benzoate;
  • esters of cinnamic acid preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester 2-cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene);
  • esters of salicylic acid preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-isopropylbenzyl ester, salicylic acid homomethyl ester;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • esters of benzalmalonic acid preferably 4-methoxybenzmalonic acid di-2-ethylhexyl ester;
  • Triazine derivatives e.g. 2,4,6-trianilino- (p-carbo-2'-ethyl-hexyloxy) -l, 3,5-triazine and octyl triazone or dioctyl butamido triazone (Uvasorb® HEB);
  • Propane-1,3-diones such as 1- (4-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione; Ketotricyclo (5.2.1.0) decane derivatives.
  • Possible water-soluble substances are:
  • UV-A filters such as, for example, 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione, 4-tert-butyl -4 '- methoxydibenzoylmethane (Parsol® 1789), l-phenyl-3- (4'-isopropylphenyl) propane-l, 3-dione and enamine compounds.
  • the UV-A and UV-B filters can of course also be used in mixtures. Particularly favorable combinations consist of the derivatives of benzoylmethane, e.g.
  • insoluble light protection pigments namely finely dispersed metal oxides or salts
  • suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and gers and mixtures thereof.
  • Silicates (talc), barium sulfate or zinc stearate can be used as salts.
  • the oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics.
  • the particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 ⁇ m.
  • the pigments can also be surface-treated, ie hydrophilized or hydrophobized.
  • Typical examples are coated titanium dioxides, such as titanium dioxide T 805 (Degussa) or Eusolex® T2000 (Merck). Silicones, and in particular trialkoxyoctylsilanes or simethicones, are particularly suitable as hydrophobic coating agents. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used. Biogenic agents and antioxidants
  • biogenic active substances include tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy) ribonucleic acid and its fragmentation products, ⁇ -glucans, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudo-ceramides, coin ceramides Plant extracts, such as To understand prunus extract, bambanus extract and vitamin complexes.
  • Antioxidants interrupt the photochemical reaction chain, which is triggered when UV radiation penetrates the skin.
  • Typical examples are amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, hnidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine) , Carotenoids, carotenes (e.g. ⁇ -carotene, ⁇ -carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (e.g.
  • thiols e.g. thioredoxin, glutathione, cysteine, Cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters
  • Dilaurylthiodipropionat Distearylthiodipropionat
  • Thiodipropionic acid and their derivatives esters, ethers, peptides, lipids, nucleotides, nucleosides and salts
  • sulfoximine compounds eg Buthioninsulfoximine, Homocysteinsulfoximin, Butioninsulfone, Penta-, Hexa-, Heptathiols
  • sulfoximine compounds eg Buthioninsulfoximine, Homocysteinsulfoxi
  • ⁇ -hydroxy fatty acids e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g
  • Cosmetic deodorants counteract body odors, mask or eliminate them.
  • Body odors arise from the action of skin bacteria on apocrine sweat, whereby unpleasant smelling breakdown products are formed. Accordingly, deodorants contain active ingredients that act as germ inhibitors, enzyme inhibitors, odor absorbers or odor maskers.
  • B 4-hydroxybenzoic acid and its salts and esters.
  • Esterase inhibitors are suitable as enzyme inhibitors. These are preferably trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT).
  • the substances inhibit enzyme activity and thereby reduce odor.
  • esterase inhibitors include sterolsulfates or phosphates, such as, for example, lanosterol cholesterol, campesterin, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and their esters, such as, for example, glutaric acid, glutaric acid monoethyl ester, and glutaric acid diethyl ester , Adipic acid, adipic acid monoethyl ester, adipic acid diethyl ester, malonic acid and malonic acid diethyl ester, hydroxycarboxylic acids and their esters such as citric acid, malic acid, tartaric acid or tartaric acid diethyl ester, and zinc glycinate.
  • Gerachsabsorber such as, for example, lanosterol cholesterol, campesterin, stigmasterol and sitosterol sulfate or phosphate
  • dicarboxylic acids and their esters such as, for example, glutaric acid,
  • Odor absorbers are not effective against bacteria. They contain, for example, the main component of a complex zinc juice of ricinoleic acid or special, largely odorless fragrances that are known to the person skilled in the art as "fixators", such as, for example, B. extracts of Labdanum or Styrax or certain abietic acid derivatives. Fragrance agents or perfume oils act as odor maskers and, in addition to their function as odor maskers, give the deodorants their respective fragrance. Perfume oils are, for example, mixtures of natural and synthetic fragrances.
  • Natural fragrances are extracts of flowers, stems and leaves, fruits, cargo bowls, roots, woods, herbs and grasses, needles and branches as well as resins and balms. Animal raw materials, such as civet and castoreum, are also suitable.
  • Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate.
  • the ethers include, for example, benzyl ethyl ether
  • the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal
  • the ketones include, for example, the jonones and methylcedryl ketone
  • the alcohols anethole citronell Eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and Te ⁇ ineol
  • the hydrocarbons mainly include Te ⁇ ene and balsams.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, for example sage oil, chamomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labdanum oil and lavandin oil.
  • Antiperspirants reduce sweat formation by influencing the activity of the eccrine sweat glands and thus counteract armpit wetness and body odor.
  • Aqueous or anhydrous formulations of antiperspirants typically contain the following ingredients:
  • non-aqueous solvents such as As ethanol, propylene glycol and / or glycerin.
  • Salts of aluminum, zirconium or zinc are particularly suitable as astringent antiperspirant active ingredients.
  • suitable antiperspirant active ingredients are e.g. Aluminum chloride, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate and their complex compounds z. B. with 1,2-propylene glycol.
  • customary oil-soluble and water-soluble auxiliaries can be present in smaller amounts in antiperspirants. Such oil soluble aids can e.g. his:
  • Usual water-soluble additives are, for example, preservatives, water-soluble fragrances, pH-adjusting agents, for example buffer mixtures, water-soluble thickeners, for example water-soluble natural or synthetic polymers such as, for example, xanthan gum, hydroxyethyl cellulose, polyvinylpyrrolidone or high molecular weight polyethylene oxides. film formers
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-trimythylpentyl) -2- (1H) -pyridinone monoethanolamine salt
  • Baypival® (climbazole)
  • Ketoconazol® (4-acetyl) are used as anti-dandruff agents -l - ⁇ - 4- [2- (2.4-dichloro-phenyl) r-2- (1H-imidazole-1-methyl) -l, 3-dioxylan-c-4-ylmethoxyphenyl ⁇ piperazine, ketoconazole, elubiol, selenium disulfide, sulfur colloidal, sulfur polyethylene glycol sorbitan monooleate, sulfur ricinole polyhexylate, sulfur tar distillates, salicylic acid (or in combination with hexachlorophene), undexylenic acid monoethanol amide sulfosuccinate sodium salt, Lamepon® UD (protein undecy
  • Montmorillonites, clay minerals, pemulene and alkyl-modified carbopol types can serve as swelling agents for aqueous phases. Further suitable polymers or swelling agents can be found in the overview by R. Lochhead in Cosm.Toil. 108, 95 (1993).
  • Possible insect repellents are N, N-diethyl-m-toluamide, 1,2-pentanediol or ethyl butyl acetylaminopropionate
  • Dihydroxyacetone is suitable as a self-tanner.
  • Arbutin, ferulic acid, kojic acid, coumaric acid and ascorbic acid (vitamin C) can be used as tyrosine inhibitors, which prevent the formation of melanin and are used in depigmenting agents.
  • Hvdrotrope ferulic acid, kojic acid, coumaric acid and ascorbic acid
  • Hydrotropes such as ethanol, isopropyl alcohol or polyols can also be used to improve the flow behavior.
  • Polyols that come into consideration here preferably have 2 to 15 carbon atoms and at least two hydroxyl groups.
  • the polyols can also contain further functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are
  • Alkylene glycols such as ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons; technical oligoglycerol mixtures with a degree of self-condensation of 1.5 to 10 such as technical diglycerol mixtures with a diglycerol content of 40 to 50% by weight; Methyl compounds, such as, in particular, trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol; Lower alkyl glucosides, in particular those with 1 to 8 carbons in the alkyl radical, such as methyl and butyl glucoside;
  • Sugar alcohols with 5 to 12 carbon atoms such as sorbitol or mannitol, sugars with 5 to 12 carbon atoms, such as glucose or sucrose;
  • Dialcohol amines such as diethanolamine or 2-amino-1, 3-propanediol.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid as well as the silver complexes known under the name Surfacine® and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance.
  • Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, cumin, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, dried lica, celery, cardamom, costus, iris, calmus), woods (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), needles and twigs (spruce, fir , Pine, mountain pine), resins and balms (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linylbenzoate, benzyl formate, ethylmethylphenylglycinate, allylcyclohexylpropylate propylate, pentylate propylate.
  • the ethers include, for example, benzyl ethyl ether
  • the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal
  • the ketones include, for example, the jonones, ⁇ -isomethylionone and methylcedryl ketone
  • the alcohols Anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and teineol
  • the hydrocarbons mainly include teenees and balms.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, for example sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavolanum oil.
  • Suitable flavors are, for example, peppermint oil, spearmint oil, anise oil, star anise oil, caraway oil, eucalyptus oil, fennel oil, lemon oil, wintergreen oil, clove oil, menthol and the like.
  • the dyes used can be those substances which are suitable and approved for cosmetic purposes, as described, for example, in the publication "Cosmetic Dyes” by the Dye Commission of the German Research Foundation, Verlag Chemie, Wein- Heim, 1984, p.81-106 are compiled. Examples are culinary red A (CI 16255), patent blue V (CI42051), indigotine (CI73015), chlorophyllin (CI75810), quinoline yellow (CI47005), titanium dioxide (CI77891), indanthrene blue RS (CI 69800) and madder varnish (CI58000). Luminol may also be present as the luminescent dye. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40% by weight, based on the composition.
  • the agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
  • the ohgoglucosamines used in the examples have a weight average molecular weight of 600 to 1000 g / mol and a degree of acetylation of less than 20%.
  • fibroblasts After an incubation of 72 h in a nutrient solution, fibroblasts form saturated monolayers, the fibroblasts cease their activity and growth stops.
  • Such systems are suitable for a number of investigations:
  • Glutathione is a peptide that is produced by the cells to protect against oxidative stress and environmental toxins, especially against heavy metals.
  • the three amino acids involved in the reduced form of the GSH are linked by cytoplasmic enzymes that require ATP for activation.
  • An increase in GSH concentration leads to an increase in glutathione S-transferase activity, a detoxification enzyme.
  • the GHS content was determined using the Hissin method [cf. Anal. Biochem. 74, 214-226 (1977)].
  • ATP adenosine triphosphate
  • the regenerative effects of the test substances were investigated on human fibroblasts.
  • the fibroblasts were incubated in a nutrient medium for 1 day at 37 ° C. and 5% by volume CO, the nutrient medium was exchanged for a medium which contained the test substances, and again incubated for 3 days at 37 ° C.
  • the protein content in the cells and the concentrations of GHS, ATP and DNA were then determined.
  • the results are summarized in Table 1.
  • the results of 3 series of measurements with triple determination in% -rel compared to a blank sample are given.
  • Table 1 Growth and survival stimulating effect (in% rel.)
  • test substances stimulate the metabolism with regard to the growth and protection of the fibroblasts.
  • UVB was chosen as a stress factor because the rays cause cutaneous inflammation (erythema, edema) by activating arachidonic acid-releasing enzymes, such as phospholipase A2 (PLA2).
  • PHA2 phospholipase A2
  • the influence of UVB rays on the keratinocytes was determined in vitro via the release of cytoplasmic enzymes, such as LDH (lactate dehydrogenase), which runs parallel to cell damage and the formation of PGE2.
  • a keratinocyte culture with fetal calf serum was set up and inoculated with the test substances 3 days later (after storage at 37 ° C. under an atmosphere with 5% CO 2 content). After an incubation of 36 h at 37 ° C and a CO 2 level of 5% by volume, the nutrient medium was replaced by an electrolyte solution and the fibroblasts were damaged with a defined amount of UVB radiation (30 mJ / cm 2 ; radiator: Duke GL40E ). The amount of keratinocytes was determined after trypsination using a cell counter, and the LDH concentration was determined enzymatically. The results are summarized in Table 2. The activity is given in% -rel against a standard as the mean of two test series with double determination. Table 2 Effect against UVB rays (in% rel.)
  • test substances significantly reduce the harmful effects of UVB rays and in particular reduce the release of LDH and PGE2.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne l'utilisation d'oligoglucosamines dans des préparations cosmétiques ou dermatologiques pour stimuler le métabolisme de la peau chez l'homme.
EP03789355A 2003-01-23 2003-12-19 Utilisation d'oligoglucosamines dans des preparations cosmetiques ou dermatologiques Withdrawn EP1585495A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP03789355A EP1585495A1 (fr) 2003-01-23 2003-12-19 Utilisation d'oligoglucosamines dans des preparations cosmetiques ou dermatologiques

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03290167A EP1440683A1 (fr) 2003-01-23 2003-01-23 Utilisation des oligoglucosamines dans des compositions cosmétiques ou dermatologiques
EP03290167 2003-01-23
PCT/EP2003/014599 WO2004064800A1 (fr) 2003-01-23 2003-12-19 Utilisation d'oligoglucosamines dans des preparations cosmetiques ou dermatologiques
EP03789355A EP1585495A1 (fr) 2003-01-23 2003-12-19 Utilisation d'oligoglucosamines dans des preparations cosmetiques ou dermatologiques

Publications (1)

Publication Number Publication Date
EP1585495A1 true EP1585495A1 (fr) 2005-10-19

Family

ID=32524272

Family Applications (2)

Application Number Title Priority Date Filing Date
EP03290167A Withdrawn EP1440683A1 (fr) 2003-01-23 2003-01-23 Utilisation des oligoglucosamines dans des compositions cosmétiques ou dermatologiques
EP03789355A Withdrawn EP1585495A1 (fr) 2003-01-23 2003-12-19 Utilisation d'oligoglucosamines dans des preparations cosmetiques ou dermatologiques

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP03290167A Withdrawn EP1440683A1 (fr) 2003-01-23 2003-01-23 Utilisation des oligoglucosamines dans des compositions cosmétiques ou dermatologiques

Country Status (5)

Country Link
US (1) US20060165631A1 (fr)
EP (2) EP1440683A1 (fr)
JP (1) JP2006514074A (fr)
KR (1) KR20050092783A (fr)
WO (1) WO2004064800A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5023311B2 (ja) * 2005-11-06 2012-09-12 ビーエイチエヌ株式会社 皮膚障害の改善及び／又は予防のための組成物
KR100878585B1 (ko) 2006-06-16 2009-01-15 국립암센터 글루코사민, 글루코사민 유도체 또는 이들의 염을 포함하는항암감작제
EP1958638A1 (fr) * 2007-02-14 2008-08-20 Polichem S.A. Utilisation de chitosanes pour augmenter la vitesse de pousse des ongles
EP2152757A1 (fr) * 2007-05-02 2010-02-17 Agency for Science, Technology and Research Fonctionnalisation de nanoparticules de dérivés de glucosamine
JP2009108019A (ja) * 2007-10-30 2009-05-21 Bhn Kk 紫外線抵抗力増強用皮膚外用剤
PL2480090T3 (pl) 2009-09-24 2014-04-30 Unilever Nv Środek dezynfekujący zawierający eugenol, terpineol oraz tymol
KR101346661B1 (ko) * 2010-11-15 2014-02-06 부경대학교 산학협력단 키토올리고당을 포함하는 피부 노화 방지용 화장료 조성물
CN103354741B (zh) 2010-12-07 2016-01-13 荷兰联合利华有限公司 口腔护理组合物
JP5715434B2 (ja) * 2011-02-15 2015-05-07 日本水産株式会社 ヒアルロン酸産生増強剤
EP2773315B1 (fr) 2011-11-03 2015-07-08 Unilever N.V. Composition pour hygiène personnelle
EP3436467A4 (fr) * 2016-03-30 2020-03-18 Ayuvis Research, Inc. Nouvelles compositions et méthodes thérapeutiques
WO2018099931A1 (fr) * 2016-12-01 2018-06-07 Unilever Plc Composition antitranspirante comprenant du chitosane
EP3421568A1 (fr) * 2017-06-27 2019-01-02 Basf Se Utilisation de l'oligoglucosamine en tant qu'inhibiteur de schiste
CN112137899B (zh) * 2020-09-18 2022-08-05 北京昊圆华美科技有限公司 富勒烯c60乳液及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62273905A (ja) * 1986-05-21 1987-11-28 Katakura Chitsukarin Kk 化粧料
IT1213384B (it) * 1986-11-24 1989-12-20 Lab Derivati Organici Mediolan Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
JP2608756B2 (ja) * 1988-04-18 1997-05-14 焼津水産化学工業株式会社 化粧料
JPH0278603A (ja) * 1988-09-14 1990-03-19 Pias Arise Kk 化粧料
CH675535A5 (fr) * 1988-11-28 1990-10-15 Nestle Sa
JPH04139131A (ja) * 1990-09-28 1992-05-13 San Five Kk 散布剤
FR2669340B1 (fr) * 1990-11-19 1993-01-22 Centre Nat Rech Scient Composes a liberation progressive d'oligomeres de la glucosamine, procede de preparation et applications.
IT1243260B (it) * 1990-11-26 1994-05-26 Riccardo Muzzarelli Metil pirrolidon chitosano, processo di produzione e suo uso.
JPH04210615A (ja) * 1990-11-30 1992-07-31 Rinjiro Saruno 外用皮膚剤
JP3253982B2 (ja) * 1991-03-13 2002-02-04 ピアス株式会社 にきび用化粧料
JPH04295412A (ja) * 1991-03-25 1992-10-20 Japan Happy:Kk 頭髪用育毛養毛化粧剤
DE59306229D1 (de) * 1992-03-27 1997-05-28 Ciba Geigy Ag N-Substituierte Chitosanderivate, ein Verfahren zu deren Herstellung und deren Verwendung
US5708152A (en) * 1992-03-27 1998-01-13 Ciba Specialty Chemicals Corporation N-substituted chitosan derivatives in a process for their preparation
JP3241173B2 (ja) * 1992-10-12 2001-12-25 ゴールド興産株式会社 入浴剤
US5730876A (en) * 1997-05-30 1998-03-24 Hyang-Ja You Separation and purification of low molecular weight chitosan using multi-step membrane separation process
DE19923672A1 (de) * 1999-05-22 2000-11-23 Beiersdorf Ag Kosmetische oder dermatologische Lichtschutzzubereitungen mit einem Gehalt an Dioctylbutamidotriazon und einem oder mehreren Filmbildnern und einem oder mehreren Polymeren
DE19923671A1 (de) * 1999-05-22 2000-11-23 Beiersdorf Ag Kosmetische oder dermatologische Lichtschutzzubereitungen mit einem Gehalt an Dioctylbutamidotriazon und einem oder mehreren Filmbildnern

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004064800A1 *

Also Published As

Publication number Publication date
WO2004064800A1 (fr) 2004-08-05
KR20050092783A (ko) 2005-09-22
EP1440683A1 (fr) 2004-07-28
US20060165631A1 (en) 2006-07-27
JP2006514074A (ja) 2006-04-27

Similar Documents

Publication Publication Date Title
EP1480603B1 (fr) Utilisation des esters de sucres dans des preparations cosmetiques
EP1253904B1 (fr) Utilisation d'extraits de residus de la production de vin comme actif soignant pour la peau et les cheveux
EP1284133B1 (fr) Mélanges de principes actifs
EP1487400A2 (fr) Agents cosmetiques
EP1392237A1 (fr) Preparations cosmetiques contenant un extrait de plantes germantes
EP1339421B1 (fr) Preparations cosmetiques ou dermopharmaceutiques contenant des proteines natives de la plante argania spinosa
EP1239826A2 (fr) Preparations cosmetiques et/ou pharmaceutiques
EP1461059A1 (fr) Principes actifs a utiliser en tant que produits cosmetiques et/ou pharmaceutiques, produits par la fermentation de composants et/ou d'extraits de vegetaux
WO2002089758A1 (fr) Utilisation de procyanolidines oligomeres
EP1170015A1 (fr) Utilisation des extraits du champignon Grifola frondosa
WO2002000188A1 (fr) Utilisation d"inulines et de derives d"inulines
EP1441747A2 (fr) Utilisation d'un extrait de plante dite vigna aconitfolia dans une composition cosmetique et/ou dermopharmaceutique
EP1276460B1 (fr) Utilisation de preparations contenant un extrait de la plante argania spinosa dans des produits de soin cosmetiques pour les cheveux et la peau
EP1138313A1 (fr) Proliposomes
EP1121926A9 (fr) Préparations cosmétiques contenant des extraits de Waltheria indica
WO2004064800A1 (fr) Utilisation d'oligoglucosamines dans des preparations cosmetiques ou dermatologiques
EP1437117A1 (fr) Utilisation d'acide sinapique ou/et de ses dérivés
WO2003043595A1 (fr) Agents anti-vieillissement
WO2004103332A1 (fr) Preparations cosmetiques
EP1499282A2 (fr) Compositions anti-vieillissement comprenant des extraits de l'espece arctium
DE10206353A1 (de) Verwendung von niedermolekularen Proteinhydralysaten
EP1369411A1 (fr) Compositions cosmétiques et/ou pharmaceutiques contenant des esters de rétinol
WO2004071480A1 (fr) Utilisation d'un extrait de champignons mycorhiziens
EP1252880A1 (fr) Utilisation d'hydrolysates de protéines du lait
WO2003043646A1 (fr) Melanges de substances actives contenant de l'escine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050714

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COGNIS FRANCE, S.A.S.

RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB IT

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 19/08 20060101ALI20080411BHEP

Ipc: A61K 8/73 20060101AFI20080411BHEP

RTI1 Title (correction)

Free format text: USE OF OLIGOGLUCOSAMINES IN COSMETIC PREPARATIONS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081022